Trial record 1 of 1 for:
Debio 0123-GBM-105
A Study of Debio 0123 in Combination With Temozolomide in Adult Participants With Recurrent or Progressive Glioblastoma and of Debio 0123 in Combination With Temozolomide and Radiotherapy in Adult Participants With Newly Diagnosed Glioblastoma
|
The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Know the risks and potential benefits of clinical studies and talk to your health care provider before participating. Read our disclaimer for details. |
| ClinicalTrials.gov Identifier: NCT05765812 |
|
Recruitment Status :
Recruiting
First Posted : March 13, 2023
Last Update Posted : April 24, 2024
|
Sponsor:
Debiopharm International SA
Information provided by (Responsible Party):
Debiopharm International SA
- Study Details
- Tabular View
- No Results Posted
- Disclaimer
- How to Read a Study Record
No Study Results Posted on ClinicalTrials.gov for this Study
| Recruitment Status : | Recruiting |
|---|---|
| Estimated Primary Completion Date : | September 2028 |
| Estimated Study Completion Date : | September 2028 |